DOGWOOD THERAPEUTICS ($DWTX) posted quarterly earnings results for Q1 2026 on Thursday, May 14th. The company reported earnings of -$0.15 per share, beating estimates of -$0.26 by $0.11. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $DWTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
DOGWOOD THERAPEUTICS Hedge Fund Activity
We have seen 5 institutional investors add shares of DOGWOOD THERAPEUTICS stock to their portfolio, and 6 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MARSHALL WACE, LLP added 11,655 shares (+inf%) to their portfolio in Q4 2025, for an estimated $48,484
- BANK OF AMERICA CORP /DE/ added 9,399 shares (+58743.8%) to their portfolio in Q4 2025, for an estimated $39,099
- VANGUARD GROUP INC added 7,776 shares (+35.1%) to their portfolio in Q4 2025, for an estimated $32,348
- UBS GROUP AG added 5,337 shares (+305.3%) to their portfolio in Q1 2026, for an estimated $11,261
- GEODE CAPITAL MANAGEMENT, LLC added 1,695 shares (+11.2%) to their portfolio in Q4 2025, for an estimated $7,051
- TOWER RESEARCH CAPITAL LLC (TRC) removed 744 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,095
- MORGAN STANLEY removed 123 shares (-20.5%) from their portfolio in Q4 2025, for an estimated $511
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
